A synthetic α-MSH analog and melanocortin-receptor agonist studied in pigmentation research.
For Research Use Only
PT-141
A cyclic melanocortin-receptor agonist studied in melanocortin-signalling research.
Certificate of analysis on this page
Fast, tracked shipping
Research overview
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH), a lactam-bridged analog of α-melanocyte-stimulating hormone and the C-terminal free-acid analog of Melanotan II, supplied as a research reference standard. In the reported literature it is characterized as a melanocortin-receptor agonist with activity at the MC3R and MC4R subtypes.
It is studied in melanocortin-receptor pharmacology, melanocortin-signalling, and pigmentation-research (melanogenesis) models across cell and animal systems. Supplied lyophilized; for research use only.
Also known as: Bremelanotide, PT 141, PT141, cyclo-[Nle4,Asp5,D-Phe7,Lys10]-α-MSH-(4-10)
Lot 0427199 · CAS 189691-06-3 · MW 1025.2 g/mol · ≥99.0% HPLC
Research areas
- Melanocortin-receptor pharmacology
- Melanocortin-signalling models
- Pigmentation-research (melanogenesis) models
Documentation
Certificates of analysis
Every lot is third-party tested by HPLC and mass spectrometry. View the certificate for the current lot, or pull the COA for an earlier lot you may already have on the bench.
Each certificate reports HPLC purity, mass-spectrometry identity, appearance, and net peptide content for that specific lot.
Related research standards
A copper peptide studied in hair-follicle, angiogenesis, and skin-research models.
For Research Use OnlyA popular peptide in tissue-repair and recovery research.
For Research Use Only